Avid Bioservices Inc (CDMO)

[BioChica]

Of course it would be an even better sign of improved MOS. But since they did not PR another extension. I am sure they reached the %80 percent mark if that is the trigger. It takes a month or two to compile the data. Probably not as long as a double blind trial. I am sure they have been collecting data from the time patients started expiring. It's a safe bet, we get a PR within the time table they set.